BioStock: PHI´s CEO comments on latest advancements

March 29, 2023
Language flag

In 2022, medtech company Phase Holographic Imaging conducted a rights issue that added over 57 million SEK to its coffers. Since then, and with a new focus on regenerative medicine, the company has been attracting more attention, not least by adding the Swiss investor company Altium as a new major shareholder. BioStock reached out to PHI´s CEO, Patrik Eschricht, to learn more about the visions moving forward.

Read the full interview with Patrik Eschricht on biostock.se.

Latest News

Directed issue registered at the Companies Registration Office

PHI Board of Directors’ proposal on a directed issue to Altium S.A. was resolved on the extraordinary general meeting on November 15, 2023. The directed issue has now been registered at the Swedish Companies Registration Office.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 15 november 2023

Phase Holographic Imaging PHI AB (publ) held an extraordinary general meeting on November 15, 2023. The following resolutions were passed at the meeting.
BioStock-PHI-CEO-reflects-on-the-company-momentum

BioStock: PHI’s CEO reflects on the Company’s momentum

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
See All News